Skip to main content

Table 1 Baseline characteristics and outcomes of patients treated for peritoneal carcinomatosis (N = 101)

From: Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Characteristic

Mean (SD)

Frequency n (%)

Age of primary diagnosis in years

  

Mean

52.3 (13.4)

 

Sex

  

Male

 

49 (48.5)

Female

 

52 (51.5)

Primary Tumor Diagnosis

  

Appendiceal

 

48 (47.5)

Colorectal

 

34 (33.7)

Gastric

 

7 (6.9)

Ovarian

 

3 (3.0)

Sarcoma

 

3 (3.0)

Others

 

6 (5.9)

Grade of primary tumor (n = 85)

  

Grade 1 (Well differentiated)

 

36 (42.9)

Grade 2 (Moderately differentiated)

 

23 (27.4)

Grade 3 (Poorly differentiated/signet ring)

 

25 (29.8)

Preoperative imaging

  

Computed tomography (CT) scan

 

89 (88.1)

Magnetic resonance imaging (MRI) scan

 

41 (40.6)

Positron emission tomography (PET) scan

 

62 (69.7)

Intraoperative PCI score (n = 74)

15.5 (11.7)

 

HIPEC completed

 

73 (72.3)

Completeness of cytoreduction (n = 65)

  

CC0

 

52 (80.0)

CC1

 

9 (13.9)

CC2

 

4 (6.2)

Length of stay

11.3 (9.1)

 

Grade 3 to 5 complications

 

15 (20.5)

Chemotherapy received

 

46 (45.5)

Before CRS

 

16 (34.8)

After CRS

 

19 (41.3)

Both before and after CRS

 

11 (23.9)

Patients alive and under follow up

 

82 (81.2)

Status at last office visit (n = 82)

  

No disease

 

31 (37.8)

Stable disease

 

24 (29.3)

Progressive disease

 

27 (32.9)

  1. CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; PCI, peritoneal carcinomatosis index.